Maravai LifeSciences Holdings, Inc. Class A Common Stock Stock Prediction
AI-powered sentiment analysis and prediction trends for MRVI, updated each market day.
MRVI AI Sentiment
AI predicts Maravai LifeSciences Holdings, Inc. Class A Common Stock stock is likely to decrease over the next 10 market days.
Prediction date: April 10, 2026
Subscribers see precise scores, buy/sell targets, and full analytics.
About Maravai LifeSciences Holdings, Inc. Class A Common Stock
Maravai LifeSciences Holdings Inc is a life sciences company providing products and services to enable the development of drugs, therapeutics, vaccines and diagnostics, and to support research on human disease. Its product portfolio includes complex nucleic acids, custom enzymes and antibody-based solutions for therapeutic, vaccine, diagnostic and biopharmaceutical production applications. The Company operates through two segments: TriLink, which generates maximum revenue from North America and provides nucleic acid products and services including mRNA, oligonucleotides and related technologies; and Cygnus, which provides biologics safety testing products and services including host cell protein ELISA kits, impurity detection assays and related reagents and services.
Sector
Exchange
Market Cap
$455,251,633
Cap Tier
Employees
435
Headquarters
SAN DIEGO, CA
Listed Since
Nov. 20, 2020
Website
MRVI Sentiment Trend — Last 30 Predictions
Sentiment zones: Bullish · Neutral · Bearish
MRVI Volatility
Maravai LifeSciences Holdings, Inc. Class A Common Stock has shown high price volatility over the last 5 trading days. High volatility means larger price swings — this can present both opportunity and risk for traders.
